Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000014

Options or other derivatives

  • Chief Medical Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schecter Alison D. · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-01-02 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +100,000 $2.30 2030-01-01 100,000 100,000 D
Loading xslF345X03/wf-form4_157835929977150.xml…